Gluvan 50 mg is an oral antidiabetic medication containing Vildagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor. It is designed to improve glycemic control in adults with type 2 diabetes mellitus by enhancing the body's natural incretin system, which increases insulin release and decreases glucagon secretion in a glucose-dependent manner.